ECENTLY, AN INCREASING number of hematopoietic growth factors have been identified, cloned, and subsequently introduced to experimental and clinical investigation as recombinant products. The factor responsible for the developmental defect of the Steel mouse, which is the ligand for a tyrosine kinase receptor, c-kit, has been cloned and termed stem cell factor (SCF).'.' Although SCF was initially identified by its ability to stimulate proliferation of primitive hematopoietic progenitors, it also stimulates the growth of committed erythroid and myeloid progenitors by acting synergistically with lineage-specific factors such as erythropoietin (EP), granulocyte-macrophage colony-stimulating factor (GM-CSF), and granulocyte colony-stimulating factor (G-CSF).3-5 Using highly purified peripheral blood burst-forming units-erythroid (BFU-E), we previously demonstrated that BFU-E need direct interaction with SCF and continue to be dependent on SCF for the first 7 days of their erythroid maturation. ' Because these recombinant factors have profound effects on hematopoietic cells and are being considered and tested for clinical use, it is important to understand the underlying means by which they produce their effects and the nature of expanded during this culture period, and total production of benzidine-positive cells plus hemoglobin synthesis were ultimately increased. To determine the effect of SCF on individual ECFC, single-cell cultures were performed in both semisolid and liquid media. These cultures demonstrated that SCF, in the presence of EP and IGF-1, acted on single cells and their descendants t o delay erythroid differentiation while substantially stimulating cellular proliferation, without an enhancement of viability of the initial cells. This was also evident when the effect of SCF was determined using clones of ECFC derived from single BFU-E. Our experiments demonstrate that SCF acts on individual day-6 ECFC t o retard erythroid differentiation while simultaneously providing enhanced proliferation by a process apparently independent of an effect on cell viability or programmed cell death. their interactions. Recently, reduction of apoptosis (programmed cell death) has been recognized as a critical process in the regulation of hematopoiesis. Although hematopoietic growth factors appear to affect both proliferation and maturation of target cells at the same time, it is possible that these growth factors principally maintain viability of the cells by reducing apoptosis and, thereby, allow the hematopoietic progenitor cells to undergo continuous stages of development. In a murine erythroid cell system, Koury and Bondurant' reported that EP prevents apoptosis of progenitor cells. Using day-6 human erythroid colony-forming cells (ECFC), which mainly consist of colony-forming units-erythroid (CFU-E), we previously demonstrated that EP, SCF, and insulin-like growth factor 1 (IGF-1) each reduced apoptosis.' However, when we further investigated the effects of EP, IGF-l, and SCF on proliferation, maturation, and survival of highly purified ECFC in a serum-free medium, it appeared that proliferation and maturation of ECFC were regulated in a separate manner by these hormones.' While EP maintained the survival of day-6 erythroid progenitor cells, addition of SCF to EP resulted in a marked cellular proliferation and the accumulation of cells with a markedly immature erythroid morphology. This proliferation, induced by the addition of SCF to EP, was associated with the expansion of cells with the capacity to form erythroid colonies without a significant additional reduction of apoptosis beyond that seen with EP alone.' Two scenarios can explain this phenomenon. (1) By reducing apoptosis of a small portion of the ECFC, SCF might enhance the survival and outgrowth of a small subset of cells, which are relatively immature and possess a higher proliferative potential. ( 2 ) SCF might directly increase the proliferation of individual ECFC, irrespective of an additional effect on apoptosis. To distinguish between these two possibilities, the effect of SCF on ECFC was investigated both by serum-free liquid culture and serum-free single-cell semisolid culture. These investigations indicate that SCF delayed erythroid differentiation among the progeny of individual day-6 ECFC, while it substantially increased the number of progeny derived from individual ECFC. These effects were not the result of increased survival of progeny cells, ie, the prevention of apoptosis, but rather were direct effects on individual cells to increase the probability that they would divide while maintaining an immature differentiation state.
MATERIALS AND METHODS
Blood. Blood was obtained from normal volunteers after informed consent. These studies were approved by the Vanderbilt University (Nashville, TN) and Department of Veterans Affairs Medical Center (Nashville, TN) Institutional Review Boards. Approximately 400 mL of peripheral blood were collected in sodium heparin (Upjohn CO, Kalamazoo, MI) at a final concentration of 20 U/mL.
Generation of ECFC. ECFC were prepared by a modified method previously described."' Light-density mononuclear cells were obtained by density centrifugation using Ficoll-Hypaque (1.077 g/pL). Platelets were removed by cell centrifugation through phosphate-buffered saline (PBS) containing 10% bovine serum albumin (BSA; Intergen CO, Purchase, NY). This was followed by T-lymphocyte depletion using sheep erythrocyte rosetting and by adherent cell depletion with overnight incubation in polystyrene tissue culture flasks at 37°C. Negative panning was then performed using CDllbl OKM*I, CD2/0KT*11, CD45/MYll, and CD16MY23 monoclonal antibodies to purify BFU-E to approximately 0.4%. The remaining cells were then cultured in 0.9% methylcellulose containing 30% fetal calf serum (FCS; Hyclone Laboratories, Logan, UT), 0.5% deionized BSA, recombinant human EP (rEP, 2 U/mL; Amgen, Inc, Thousand Oaks, CA), recombinant human interleukin-3 (rlL-3, 50 U/mL; Amgen), moVL 2-mercaptoethanol, penicillin 500 U/ mL, streptomycin 40 pg/mL, and Iscove's modified Dulbecco's medium (IMDM; Sigma Chemical CO, St Louis, MO) at 37°C in a high humidity 5% CO,/%% air incubator for 5 days to generate ECFC (day-6 cells). The cells were then collected from the methylcellulose, and ECFC were further enriched by centrifugation through 10% BSA and then over Ficoll-Hypaque. This preparation generally resulted in 94% viable ECFC of 30% to 90% purity? Serum-free liquid culture of ECFC. The day-6 ECFC were incubated at 37°C in 0.5 mL of serum-free liquid medium consisting of 0.5% deionized, delipidated, dialyzed crystalline BSA (C-BSA-3D); iron-saturated transfenin (Sigma; 300 pg/mL); lipid suspension (oleic acid, 2.8 pg/mL; L-a-phosphatidylcholine, 4.0 pg/mL; cholesterol, 3.9 pg/mL; Sigma); penicillin; streptomycin; and 50% IMDW 50% F-l2[HAM] (Sigma), which was prepared as previously described." Cell concentrations were 2 X lo5 to l X lo6 mL. When the rate of 59Fe incorporation into heme was measured, the concentration of transfemn was reduced to 100 pg/mL. Combinations of rEP (0.01 to 10 U/mL), recombinant human IGF-1 (rIGF-l, 100 ng/mL; Intergen CO), and recombinant human SCF (rSCF, l to 100 ng/mL; Amgen) were added as indicated. When the ECFC were cultured for longer than day 11, the cells were collected by centrifugation at 1,OOOg and recultured in fresh media every 3 to 4 days. The cell concentration was reduced to no more than 106/mL at each medium change.
Measurement of DNA synthesis. The proliferative response of ECFC to growth factors was assessed by measuring the rate of ['Hlthymidine incorporation into DNA, as previously described." The ECFC (IO' cells) were incubated in 0.5 mL of serum-free culture medium containing various concentrations of rEP, rSCF, and/or rIGF-l at 37°C for 40 hours, followed by further incubation with 1.25 pCi of ['Hlthymidine (6.7 Ci/mmol; New England Nuclear Corp, Boston, MA) at 37°C for 1 hour. The cells were collected by centrifugation at 1,000g for 5 minutes, washed with IMDM, and placed in 10% ice-cold trichloroacetic acid (TCA). The precipitates were collected on filter discs (type GF/A; Whatman, Maidstone, UK), washed with 5% ice-cold TCA followed by 95% ethanol, airdried, placed in a scintillant, and counted in a scintillation counter. The rate of ['Hlthymidine uptake was expressed as counts per minute (cpm) per milliliter of culture.
Determination of benzidine positivity and 59Fe incorporation into heme. Aliquots of the serum-free cultures were cytocentrifuged onto glass slides at the indicated times, and the slides were stained with 3.3' dimethoxybenzidine-hematoxylin. The percentage of benzidine-positive cells was determined by counting 400 cells. The net number of benzidine-positive cells was determined by multiplying the fraction of the mononuclear cells that stained with benzidine and the number of viable cells identified by trypan blue exclusion. Heme synthesis by ECFC was determined serially during serum-free culture with rEP (1 U/mL) plus rIGF-l (100 ng/mL) in the presence or absence of rSCF (100 ng/mL) after 4 hours of incubation with 59Fe, as previously described."
Assay of ECFC. The erythroid colony-forming capacity of the ECFC was determined by the plasma clot method. Two hundred to eight hundred cells were added to a total 0.2 mL medium consisting of IMDM, 15% FCS, 15% heat-inactivated pooled human AB serum, 0.5% human serum albumin (American Red Cross Blood Services, Washington, DC), 1.5 mmoliL aminocaproic acid (Elkins-Sinn, Inc, Cherry Hill, NJ), 2 mg/mL fibrinogen (Fibrinogen Kabi, grade L; Kabi Diagnostica, Stockholm, Sweden), 0.2 U/mL bovine thrombin (Parke-Davis Pharmaceuticals, Moms Plains, NJ), 50 ng/mL rSCF, 1 U/mL rEP, penicillin, and streptomycin. The incubation was performed in 48-well flat-bottomed tissue culture plates (Linbro; Flow Laboratories, Inc, McLean, VA) in a 5% CO, incubator at 37°C for 7 days, and the colonies were fixed and stained with 3,3' dimethoxybenzidine-hematoxylin. Colonies of two or more hemoglobinized cells were scored as ECFC, and the number of ECFC per microliter at the onset of the culture was designated as 100%. This value was corrected for the dilution factor after each medium change.
Serum-free single-cell cultures of ECFC. To determine the effect of SCF on proliferation and maturation of individual ECFC, erythroid clusters originating from single cells were established in semisolid serum-free cultures by limiting dilution. The ECFC (lo5 cells) were resuspended in 1 mL of IMDM containing 0.1% C-BSA-3D. Aliquots of cells (400/4 pL) were each added to 20 mL of serumfree medium, which also contained aminocaproic acid (1.5 mmoV L), rEP (1 U/mL) plus rIGF-l (100 ng/mL), with or without rSCF (100 ng/mL), to achieve a cell concentration of 20/mL. Fibrinogen (2 mg/mL) and bovine thrombin (0.2 UlmL) were added, and 50-pL aliquots were transferred to 96-well flat-bottomed tissue culture plates (Linbro). Immediately after the clots were formed, each well was observed through an inverted microscope, and wells containing two or more cells were excluded from the study. This procedure resulted in 27% of the wells containing single cells (mean of six incubations). The incubations were continued in a 5% CO, incubator at 37°C for 4 days. The wells were then fixed and stained with 3,3' dimethoxybenzidine-hematoxylin.
When the fate of single cells was being observed with the inverted microscope during this culture period, 50 pL of liquid culture was prepared and incubated as described above, but without aminocaproic acid, fibrinogen, or bovine thrombin. Serial observations were made over 4 days, and cell death was determined by the deterioration of cellular integrity with a complete lack of cell proliferation using inverted microscopy. The cells were stained by the addition of a benzidine solutioni4 on day 10.
Analysis of progeny of individual BFU-E in serum-jree medium. The effect of rSCF was also determined on pairs of semisolid serumfree cultures containing ECFC that originated from a single BFU-E. More highly purified peripheral blood BFU-E were prepared as previously de~cribed.'~ The BFU-E (day-l cells) were diluted in liquid medium consisting of IMDM, 30% FCS, rEP (1 U/mL), rlL-3 (50 U/mL), penicillin, and streptomycin to achieve a cell concen- days to obtain day-6 ECFC. Wells containing more than two cells, which originated from a single peripheral blood BFU-E, were transferred to 0.5 mL of serum-free medium consisting of MDMl F12
[HAM], C-BSA-3D (0.5%), iron-saturated transfenin (300 pg/ mL), lipid suspension, rEP (1 U/mLj, rIGF-1 (100 ng/mL), aminocaproic acid, penicillin, and streptomycin. The suspension was divided into two polystyrene culture tubes, and rSCF (100 ng/mLj was added to one. After addition of fibrinogen and thrombin, 50-pL cell suspensions were transferred to 96-well flat-bottom culture plates. The clots were incubated at 37°C for 4 days and were then fixed and stained with 3,3' dimethoxybenzidine-hematoxylin on day 10. Data are presented as means 2 SD, and significance was calculated using the t test. For analysis of benzidine-negative progeny of individual BFU-E in Table 4 , a weighted mixed model analysis of variance was performed to test for treatment effect (fixed effect in the model) on percent benzidine-negative clusters while adjusting for random effects of subjects (pair number). The analysis was weighted by the number of clusters in each group. Analysis was performed using the SAS GLM procedure (SAS version 6; SAS Institute Inc, Cary, NC). Mantel-Haenszel analysis was also performed using StatXact, version 2 (CYTEL Software Corp, Cambridge, MA), and showed consistent results of a treatment effect (14 2-X-2 tables). Only the analysis of variance (ANOVA) results are quoted.
RESULTS
SCF dose-response curve for day-4 ECFC. Previous work has shown that, after the addition of rSCF to day-6 cells, [3H]-thymidine incorporation into DNA parallels the number of accumulating erythroid progeny on successive days? The effect of increasing concentrations of rSCF on proliferation of ECFC was determined by measuring DNA synthesis using rH]-thymidine in the presence of rEP (1 U/mL) plus rIGF-1 (100 ng/&, Fig 1A) . A dose-dependent stimulation of DNA synthe- sis was evident ( r = .95). When DNA synthesis per viable cell was calculated, addition of rSCF (100 n g / d ) increased the incorporation of [3H]thymidine approximately threefold compared with that seen without rSCF, in the presence of rEP plus rIGF-1 (data not shown). The effect of SCF was also determined in combination with different concentrations of rEP (Fig 1B) . While addition of rEP up to 10 U/mL by itself had only a minimal effect on DNA synthesis, increasing concentrations of rEP substantially enhanced DNA synthesis in the presence of rIGF-1 (100 ng/mL). Addition of a relatively low concentration of rSCF (10 ng/mL) to rIGF-1 further increased DNA synthesis at each concentration of rEP.
SCF retards differentiation of ECFC and enhances the number of ECFC. When ECFC were cultured with rSCF, rEP, and rIGF-1, the day-l4 cells retained immature features, while ECFC cultured with rEP plus rIGF-1 disclosed terminal erythroid maturation with nuclear condensation and enucleation.g To quantitate the further effects of SCF on the differentiation of ECFC, the percentage of benzidine-positive cells was determined serially in serum-free liquid culture (Fig 2A) . The majority of the cells (88%) cultured with rEP (1 U/mL) plus rIGF-1 (100 ng/mL) turned benzidine positive by day 10. When rSCF (100 ng/mL) was added to the cultures in the presence of rEP plus rIGF-l, the percentage of benzidine-positive cells was significantly decreased very early compared with the number seen without rSCF ( P < .01, days 8 through 12), and it was not until day 17 that a similar benzidine positivity was attained. The effect of increasing concentrations of rSCF in the presence of rEP and rIGF-1 was determined on day 10 of liquid culture ( Fig  2B) . A significant decrease in benzidine positivity was seen at 6 ng/mL ( P < .05), and further large decreases were evident at 10 to 100 ng/mL.
Benzidine positivity was further differentiated into three
For .05). By day 12, the total number of benzidine-positive cells was higher in the cultures containing rSCF due to greater cell proliferation ( P < .01; data not shown). This indicates that SCF delayed erythroid differentiation of the ECFC during a period when it was stimulating proliferation. 
org From
When the ECFC are incubated in liquid medium containing serum and rEP, the amount of 5yFe incorporation into the heme of hemoglobin discloses a distinctive pattern during erythroid differentiati~n.'~ If SCF affects the erythroid maturation of ECFC, the pattern of "?e uptake by ECFC should be altered concomitantly. The effect of rSCF on %e incorporation was determined in serum-free liquid culture in the presence of rEP (1 U/mL) and rIGF-1 (100 ng/mL; Fig 2C) . When ECFC were cultured without rSCF, 5yFe incorporation into heme increased rapidly during days 6 to 8, reaching a peak on day 10, and then declined. When rSCF (100 ng/mL) was added to the cultures, "Fe incorporation was significantly less during the early days of culture ( P < .01 on days 8 and 10) compared with the cells incubated without rSCF, and the peak was reached on day 16, followed by a rapid decline. This resulted in a shift of the whole curve to the right (Fig 2C) , with an increase in the area under the curve, indicating that the addition of rSCF delayed erythroid differentiation of ECFC while increasing the total amount of s9Fe incorporation into heme. This difference is even greater than that shown in Fig 2C, when the peaks of 'Te incorporation on days 10 and 16 are corrected for the 50-fold increase in cell number produced by rSCF through day 16.
The number of ECFC during this culture period was assayed by transferring aliquots of cells from serum-free liquid cultures to plasma clots and continuing the incubations for 7 additional days (Fig 2D) . When ECFC were incubated in liquid medium in the presence of rEP plus rIGF-1, but without rSCF, the ECFC number decreased rapidly after day 10 and was almost entirely lost by day 17. When rSCF was added, the number of ECFC substantially increased throughout day 1 l to day 21, resulting in a 50-fold increase by day 17 compared with day 6, and then exhibited a delayed decline.
Serum-free single-cell cultures of ECFC. Although the preceding experiments strongly suggest that SCF delays the maturation of ECFC while enhancing their proliferation, it is still possible that SCF enhanced the survival of a small, relatively immature population of ECFC that proliferated rapidly and diluted the more mature erythroid cells. To determine if SCF actually affects maturation of individual ECFC, single-cell cultures of ECFC in serum-free medium were performed using limiting dilution, and the effect of SCF was ascertained (Fig 3 and Table 2 ). After exclusion of wells with two or more cells, 100 (experiment 1) and 200 (experiments 2 and 3 ) wells for each incubation were incubated for 4 days, and the cells were fixed on day 10 and examined after benzidine staining. The number of clusters formed per number of wells with single cells was similar between the cultures without rSCF and with rSCF (rEP plus rIGF-1,80% 2 2%; rEP plus rIGF-1 plus rSCF, 79% t 11%; mean -+ SD of three experiments), indicating that, in the presence of EP, SCF did not increase cell survival of these day-6 ECFC ( Table 2) . When rSCF was added to the cultures, the number of cells per cluster was significantly increased (rEP plus rIGF-1, 3 2 1; rEP plus rIGF-1 plus rSCF, 9 t 2; P < .01; mean -I SD of three experiments; Table 2 ). Figure 3 shows the distributions of cluster sizes in all three experiments. In the presence of rSCF, at least half of all clusters are clearly shifted in size to a larger cell number. As 80% of single cells formed clusters with or without rSCF, the distributions of Fig 3 indicate that the stimulating effect of rSCF on proliferation of ECFC is not restricted to a small immature population of ECFC but, instead, is evident in the majority of ECFC. Addition of rSCF also altered the degree of erythroid maturation of many clusters. Table 2 and Fig 3 show that the percentage of clusters that contained benzidine-negative cells was significantly increased in the presence of rSCF (rEP plus rIGF-1, 7% 2 5%; rEP plus rIGF-1 plus rSCF, 46% t 5 % ; P < .01; mean 2 SD of three experiments), indicating that a delay in erythroid maturation of the cell colonies occurred in many cases along with growth stimulation by rSCF.
Typical morphologies of these day-l0 clusters are shown in Fig 4A and B . While clusters formed without rSCF were intensely stained with benzidine (Fig 4A) , those formed with rSCF were larger and frequently contained benzidine-negative cells, mixed with weakly stained benzidine-positive cells (Fig 4B) . When the incubations were performed to day 14, typical CFU-E colonies were formed without rSCF (Fig 4C) . However, the majority of colonies formed with rSCF, in the presence of rEP plus rIGF-l, were larger than those seen without rSCF, and these were well hemoglobinized (Fig 4D) . Although the colonies formed with rSCF occasionally contained benzidine-negative cells even by day 14, all the colonies were thoroughly hemoglobinized by day 17 (data not shown).
Serial observations of cultures initiated with single cells from day 6 to day 10 were performed using the liquid serumfree culture system ( Table 3 ). The numbers of wells with cell death were similar between those incubated with rSCF and those without rSCF, throughout the culture period. Together with the data from Fig 3 and Table 2 indicating that the frequency of erythroid clusters was similar between the cultures without rSCF and those with rSCF, in the presence of rEP plus rIGF-1, this again indicates that rSCF did not support survival of ECFC beyond that found with the combination of rEP plus rIGF-1. However, the number of cells per well was greater in the cultures with rSCF, and the percentage of the wells that contained benzidine-negative cells was also greater with rSCF than without rSCF.
Analysis of progeny of individuul BFU-E in serum-free medium. To determine if heterogeneity of erythroid development was still associated with the addition of rSCF when all of the ECFC were derived from the same BFU-E, a cloning experiment was performed. Highly purified peripheral blood day-l BFU-E" were suspended in liquid culture medium containing serum at a cell concentration of 20/mL, and 50 pL of cell suspension was distributed into 196 culture plate wells. This preparation resulted in 45 single BFU-Epositive wells, of which, 23 wells showed cellular proliferation after 5 days of culture. Each well with proliferating cells, which consisted of day-6 ECFC derived from a single BFU-E, was sterilely aspirated and divided into two cultures in plasma clots with serum-free medium with or without rSCF (100 ng/mL) in the presence of rEP and rIGF-1. The paired semisolid cultures were incubated for 4 days, and 14 pairs were obtained on day 10 (Table 4) Table 4 ). The clusters grown with rSCF were unequivocally larger compared with those without rSCF and contained benzidine-negative cells along with faintly benzidine-positive cells.
DISCUSSION
It is apparent that SCF is necessary to maintain normal erythropoiesis, as the S1/Sld mouse, which has a mutation in the Steel locus (SCF genomic sequence), manifests aneproliferative capacity colony-forming cells, as well as a wide variety of hematopoietic progenitor cells of human and murine origins. 17 We previously demonstrated that SCF enhances survival and proliferation of day 1 to day 7 erythroid progenitor cells.6~8~9 While EP has been shown to be an essential factor for differentiation of these cells into erythroblast~,'.~~ EP alone has only a minimal effect on the cellular proliferation of day-6 ECFC ( Fig 1B) . In the presence of EP mia.2.16 The effect of SCF has been demonstrated with high B a .
--l rSCF (ng/ml) 0 100 plus IGF-1, SCF remarkably enhanced the proliferation of ECFC in a dose-dependent manner (Fig 1A) . When Koury and Bondurant' demonstrated apoptosis of erythroid cells at late developmental stages in the absence of EP, they hypothesized that the production of the erythroid mass was regulated by EP through a modulation of cellular viability and apoptosis. The prevention of apoptosis theoretically could also be the mechanism by which other growth factors such as SCF enhance erythropoiesis by enhancing survival of erythroid progenitors, and we have previously demonstrated that SCF alone reduced apoptosis of day-6 ECFC.7 However, when we determined the effect of rSCF on DNA fragmentation as a measure of apoptosis, SCF had very little additional effect in the presence of EP, while, at the same time, it markedly stimulated [3H]thymidine incorporation into DNA. 9 The current study corroborates those observations, as SCF in the presence of EP markedly stimulated the proliferation of the day-6 ECFC without enhancing their survival, as judged by the formation of the same number of erythroid colonies as the controls in single-cell experiments (Tables 2  and 3 ). Although the colony numbers were no greater when rSCF was added, the number of cells per colony was greatly For personal use only. on October 31, 2017. by guest www.bloodjournal.org From increased. These experiments confirm, by distinctly different methods, that the proliferation of erythroid progenitors can be directly regulated by SCF in the presence of EP in a manner independent of a reduction in apoptosis. While SCF by itself clearly reduces apoptosis of erythroid progenitors, the introduction of a sufficient amount of EP to day-6 ECFC to protect against apoptosis allows this additional effect of SCF to become apparent.
In one erythroid system, it was reported that SCF enhanced erythroid differentiation, as well as proliferation of the MB-02 erythroleukemia cell line.I9 However, in our studies, the majority of ECFC incubated with rSCF plus rEP and rIGF-1 had the morphology of immature erythroblasts even on day 14, the time when ECFC usually underwent terminal erythroid maturation with nuclear condensation in cultures with only rEP and rIGF-l? When we determined the kinetics of maturation of ECFC by '9Fe uptake into heme plus benzidine positivity, it was clear that the process of erythroid maturation is delayed in cultures with rSCF, compared with cultures without rSCF, in the presence of rEP plus rIG-1 (Fig   2) . These data clearly indicate that SCF delays the erythroid differentiation of ECFC in vitro. The apparent contradiction between our results and those obtained with the MB-02 cell line" might result from the altered nature of the erythroid leukemic cell line compared with normal erythroid proge+ tor cells or the difference in the stage of erythroid maturation between ECFC and the cell line.
Wlth conventional mass-culture methods, it was possible that SCF might have been enhancing the proliferation of a relatively small fraction of immature erythroid progenitor cells, which would dilute slower growing mature erythroid cells in culture, resulting in an apparent delay in erythroid maturation. Therefore, we performed single-cell cultures to determine the fate of each erythroid progenitor. In addition, the effect of SCF was determined using paired cultures of ECFC that were derived from single BFU-E and were considered to be in a similar stage of erythroid development. A delay in erythroid maturation, along with enhanced cellular proliferation, was evident in the presence of rSCF in these assays as well (Tables 2 through 4), indicating that SCF directly reduced the fresuency of differentiation while stimulating proliferation of individual ECFC progeny. During delayed maturation of the ECFC, the usual decline in colonyforming capacity, a functional characteristic of immature erythroid cells, was also delayed (Fig 2D) . This suggests a possible si&cance in vivo for the capacity of SCF to delay erythroid maturation. By this delay, SCF may enhance the total proliferative capacity of erythroid progenitors not only by expanding cell number, but also by maintaining enhanced proliferative capacity of each cell, thereby expanding the progenitor cell pool that is capable of producing a large number of erythrocytes rapidly. Thus, the total capacity of committed erythroid progenitor cells does not appear to be as k e d as suggested in previous hypotheses, which assumed that committed hematopoietic progenitors undergo a fixed program of cellular proliferation and are controlled solely Semisolid paired cultures, each derived from a single day-l BFU-E (purity, 46% + 6%), were established on day 6, and rSCF was added to * Number of single BFU-€-derived ECFC per well on day 6.
t Number and percentage of clusters containing benzidine-negative cells after 4 days of culture.
* Delay in erythroid maturation determined by benzidine staining.
one set of the pair as indicated.
by preservation of cell viability. Under certain conditions, with an adequate combination of growth factors, committed erythroid progenitors might undergo enhanced proliferation along with delayed erythroid differentiation, to enhance total erythropoiesis. The physiologic dynamics of SCF levels within the bone mmow have not yet been determined, and SCF could have either a constitutive, permissive role in regulating erythropoiesis or a direct controlling role based on the dose-response relationship and alterations in SCF concentrations. However, blood levels of SCF have not revealed any correlation of the SCF concentration with the hematocrit or degree of erythropoiesis," which lends little support to the idea that this extraordinarily potent growth factor regulates erythropoiesis in vivo through feedback changes in its concentration. EP, which has an extended dose-response curve and a well-documented feedback inhibition that regulates its production, is the principal regulator of erythropoiesis under normal conditions.I8 Nevertheless, the in vitro studies in serum-free medium show that the large expansion of erythroid cells due to enhanced replication is not supported by EP itself, but rather by a cooperative interaction of EP with SCF.9 How, then, does SCF contribute to the regulation of erythropoiesis without evidence for changes in the blood levels or feedback inhibition? The answer appears to be in the data of Fig 1. Because SCF appears to act in a constitutive, permissive manner to support regulation of the erythroid progenitor cells, the erythroid dose-response curve would be governed by the wide variety of EP concentrations. This does not exclude the possibility that small fluctuations of the SCF concentration in the bone marrow might occur and enhance or reduce erythroid progenitor cell replication. In addition, the administration of pharmacologic concentrations of SCF would be predicted to enhance the effect of EP by enhancing the EP dose-response relationship and by providing for enhanced erythroid replication. As SCF acts on a wide variety of hematopoietic progenitor cells, any selective effect on erythropoiesis would depend on the individual dose-response relationships of SCF with these progenitors, as well as the degree of elevation of the EP levels that would accentuate the erythroid response.
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